CRISPR THERAPEUTICS AG COM CHF0.03

The current price of 0VRQ is 55.0 USD — it has increased by 1.66% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange CRISPR THERAPEUTICS AG COM CHF0.03 stocks are traded under the ticker 0VRQ.

CRISPR THERAPEUTICS AG COM CHF0.03 is going to release the next earnings report on Apr 30, 2024. Keep track of upcoming events with our Earnings Calendar.

0VRQ stock is 2.83% volatile and has beta coefficient of 2.44. Check out the list of the most volatile stocks — is CRISPR THERAPEUTICS AG COM CHF0.03 there?

0VRQ earnings for the last quarter are −1.41 USD per share, whereas the estimation was −1.99 USD resulting in a 29.12% surprise. The estimated earnings for the next quarter are 0.07 USD per share. See more details about CRISPR THERAPEUTICS AG COM CHF0.03 earnings.

Yes, you can track CRISPR THERAPEUTICS AG COM CHF0.03 financials in yearly and quarterly reports right on TradingView.

0VRQ stock has fallen by 0.36% compared to the previous week, the month change is a 21.04% fall, over the last year CRISPR THERAPEUTICS AG COM CHF0.03 has showed a 12.75% increase.

Today CRISPR THERAPEUTICS AG COM CHF0.03 has the market capitalization of ‪4.58 B‬, it has decreased by 3.97% over the last week.

No, 0VRQ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, 0VRQ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CRISPR THERAPEUTICS AG COM CHF0.03 stock right from TradingView charts — choose your broker and connect to your account.

0VRQ reached its all-time high on Jan 15, 2021 with the price of 216.5 USD, and its all-time low was 14.0 USD and was reached on Dec 16, 2021.
See other stocks reaching their highest and lowest prices.

As of Apr 30, 2024, the company has 407.00 employees. See our rating of the largest employees — is CRISPR THERAPEUTICS AG COM CHF0.03 on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CRISPR THERAPEUTICS AG COM CHF0.03 technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CRISPR THERAPEUTICS AG COM CHF0.03 stock shows the sell signal. See more of CRISPR THERAPEUTICS AG COM CHF0.03 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on CRISPR THERAPEUTICS AG COM CHF0.03 future price: according to them, 0VRQ price has a max estimate of 199.00 USD and a min estimate of 30.00 USD. Read a more detailed CRISPR THERAPEUTICS AG COM CHF0.03 forecast: see what analysts think of CRISPR THERAPEUTICS AG COM CHF0.03 and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CRISPR THERAPEUTICS AG COM CHF0.03 EBITDA is ‪−179.28 M‬ USD, and current EBITDA margin is −54.61%. See more stats in CRISPR THERAPEUTICS AG COM CHF0.03 financial statements.